SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Elan Corporation, plc (ELN)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
10345 171 0 ELN
Emcee:  Harold Engstrom Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10220reuters.com No new warnings by fda...Arthur Radley-9/16/2009
10219reuters.comArthur Radley-9/15/2009
10218Elan, J&J cut deal price, resolve Biogen dispute On Monday September 14, 200Arthur Radley-9/14/2009
10217fool.comArthur Radley-9/14/2009
10216By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--Two more caseQualified Opinion-9/14/2009
10215Teva shares off; Mylan files for generic Copaxone marketwatch.com reuters.comQualified Opinion19/14/2009
10214J&J in talks to reduce $1.5 bln Elan deal price- source reuters.comQualified Opinion-9/13/2009
10213Anyone know anything about Facet Pharm and Biogen trying to acquire with it'steve kammerer-9/11/2009
10212Data Supporting Unique Efficacy of TYSABRI Presented at the 25th Congress of thekenhott19/11/2009
10211see Davy comments for translation. comments here are welcomed, but looks to me fred hayes19/10/2009
10210Tysabri in the news MS drug Tysabri reawakens brsim119/10/2009
10209NVS reports data on the FTY720 FREEDOMS trial tomorrow: siliconinvestor.comDewDiligence_on_SI-9/9/2009
10208<i>>1 in 1,200 may overstate the risk. That formulation of the risk totDewDiligence_on_SI19/9/2009
10207<i>>Dew Diligence, my point was that risk clearly does NOT increase witDewDiligence_on_SI-9/9/2009
10206>> since she is about to start my wife on the drug through a compounding pscaram(o)uche-9/9/2009
10205>>And the number of AERs prevented by using Tysabri instead of copaxone orIRWIN JAMES FRANKEL29/9/2009
10204Dew Diligence, my point was that risk clearly does NOT increase with time on druHarold Engstrom-9/9/2009
10203With not that much more time (two years), the risk/benefit of this drug will be kenhott-9/9/2009
10202<i>>I have to take issue with the notion that risk increases with time.DewDiligence_on_SI-9/9/2009
10201I have to take issue with the notion that risk increases with time. IMO, there Harold Engstrom29/9/2009
10200Medicine's Dangerous Guessing Game Different Methods of Weighing the Risks akenhott-9/9/2009
10199The problem is that JNJ thought it was getting stock, control of AD and control Robohogs-9/7/2009
10198'morning Jon. Good point, and maybe I'm being too casual about this. Am fred hayes19/4/2009
10197The "financing" apparently called for JNJ to act in 50/50 partnerhip oRobohogs19/4/2009
10196Rats. I thot this was slam dunk for Elan. But not a big deal, Elan can fix the bfred hayes19/3/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News